baber/WOPTO huggingface dataset:
Patent NZ-535065-A (NZ)
Title: Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
Inventor: WATKINS CLARE J
Filed: 2001-09-27
Abstract: A compound of the formula (1) is described, as well as its pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, and prodrugs. A is an aryl group; Q1 is a covalent bond or an aryl leader group; J is a sulfonamide linkage of the disclosed formula; R1 is a sulfonamido substituent; and Q2 is an acid leader group. When A is a C5-20 aryl group, the aryl leader group, if present, is: a C1-7alkylene group; the sulfonamido substituent, R1, is: hydrogen, C1-7alkyl, C3-20heterocyclyl, or C5-20aryl; the acid leader group, Q is: C4-7alkylene having a backbone length of from 4 to 7 carbon atoms. The use of the compound is described to be for the manufacture of a medicament for use in the treatment of a proliferative condition.
Patent NZ-543685-A (NZ)
Title: Rotor Blade connection for wind power plant
Inventor: WOBBEN ALOYS
IPC: F03D1/06
Filed: 2004-05-14
Abstract: The disclosure relates to a rotor blade for a wind power plant provided with several holes which are embodied in the base thereof and designed in the form of passage holes extending essentially vertically with respect to the longitudinal axis of said rotor blade which also comprises transversal bolts inserted into said holes and strength members connectable to the transversal bolts. Usually, the strength members extend in the base of a rotor blade thereby weakening material in said area. The aim of said invention is to solve the problem by simplifying the structure. For this purpose, the inventive rotor blade is characterised in that the strength members extends outwards the rotor blade base in such a way that said area is aerodynamically modified in a disadvantageous manner at a hub area without detrimentally affecting the acoustic behaviour and other properties of the device since the blade base is covered by a blade spinner or arranged at least in the low-rotating rotor area.
Patent NZ-551950-A (NZ)
Title: Use of fibroblast growth factor 2 (FGF2) in the manufacture of medicament for treating asthma
Inventor: KANG SOO HYUNG
IPC: A61K38/18
Filed: 2005-05-12
Abstract: Disclosed is the use FGF2 (Fibroblast Growth Factor-2) in the manufacture of a medicament for treating or preventing asthma, chronic obstructive pulmonary disease (COPD), airway fibrosis, airway inflammation, airway hyperresponsiveness, and airway remodelling
Patent NZ-552038-A (NZ)
Title: Customer data acquisition on basis of software product licences
Inventor: JACKSON WAYNE ALBERT
Filed: 2003-11-05
Abstract: A computer implemented method of recording customer data relating to software product license data is provided. The method includes the steps of receiving software product licence data from a sales database, collating the software product license data into an analysis database, prompting questions to ask a customer, recording the responses given by the customer and integrating the responses into the analysis database.
Patent NZ-554574-A (NZ)
Title: Method and apparatus for separation of isobaric interferences
Inventor: LITHERLAND ALBERT EDWARD
IPC: H01J49/04
Filed: 2005-10-28
Abstract: A method and apparatus for separation of rare stable or radioactive isotopes from their atomic or molecular isobars in mass spectrometry (MS). The approach taken to removing atomic isobars utilizes a high transmission device for decelerating ions in combination with low energy reactions, such as ion-molecule reactions or near resonant electron transfer, in RF ion guides. The isobar is selectively depleted by electron transfer or other reactions between negative ions and gaseous targets in pressurized RF ion guides at low energies. The energy is controlled in such a way as to prevent reaction of the ion of interest while inducing reactions with the undesired isobar interference. The technique is of particular relevance to accelerator mass spectrometry (AMS) for which it allows substantial reductions in the necessary terminal voltage. The effect is to allow reductions in the size and cost of AMS installations.
Patent NZ-555439-A (NZ)
Title: Use of salinosporamide A for treating neoplastic diseases which are resistant to the chemotherapeutic agents bortezomib, dexamethasone, doxorubicin or thalidomide
Inventor: ANDERSON KENNETH C
IPC: A61K31/337
Filed: 2005-12-02
Abstract: Disclosed is the use of a salinosporamide A derivative as represented by the general formula (I) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating a neoplastic disease, wherein X is selected from the group consisting of fluorine, chlorine, bromine or iodine, and wherein the neoplastic disease is resistant to at least one other chemotherapeutic agent selected from the group consisting of bortezomib, dexamethasone, doxorubicin, and thalidomide. Also disclosed a pharmaceutical composition, which comprises a compound of formula (I) or a pharmaceutically acceptable salt thereof, and at least one additional chemotherapeutic agent selected from the group consisting of bortezomib, dexamethasone, and thalidomide.
Patent NZ-560552-A (NZ)
Title: Polymeric creping adhesives and a process for manufacturing creped fiber web product
Inventor: HILL WALTER B
IPC: D21H21/14
Filed: 2002-06-04
Abstract: A method for manufacturing a creped fiber web is disclosed, which comprises: providing a rotating cylindrical dryer surface, applying an ionene adhesive to the rotating cylindrical dryer surface to form an adhesive dryer surface, wherein the ionene polymer comprises a crosslinked polymer of an alkylamine, a haloepoxyalkane, and an amine that differs from the alkylamine; conveying a fiber web to the adhesive dryer surface drying the fiber web on the adhesive dryer surface to form a dried fiber web;and creping the dried fiber web from the adhesive dryer surface. Examples of an ionene polymer include a terpolymer of dimethylamine, epichlorohydrin, and ethylenediamine. The ionene adhesive may further include monoammonium phosphate. The ionene polymer may be water-soluble and cationic.
Patent NZ-565728-A (NZ)
Title: Bubble diverter for use with diving equipment
Inventor: MORGAN WILLIAM B
IPC: B63C11/02
Filed: 2006-09-21
Abstract: A diving helmet (10) bubble diverter comprises a front skirt portion (24) and a rear skirt portion (25) attached to the front skirt portion (24) at one end. The rear skirt portion (25) is configured for mounting onto the diving helmet breathing regulator assembly (12). The attached front and rear skirt portions (24, 25) form side pockets (46, 48) that divert exhaust air bubbles (40) away from the diver's mask when the rear skirt portion (25) is mounted onto the regulator assembly (12). The mounted rear skirt portion (25) forms a protective barrier between the exterior wall of the diving helmet (10) and the exhaust whisker (20) of the breathing regulator assembly (12) that prevents air bubbles (40) exiting the whisker (20) from coming into contact with the diving helmet (10) during diving activities.
Patent NZ-570565-A (NZ)
Title: A screen and method for visually obscuring a moving object to improve a users reflexes
Inventor: FITTLER MARSHALL
IPC: A63B69/00
Filed: 2007-01-18
Abstract: Disclosed is a screen and a method for its use in sports training or sports skills development. The screen apparatus includes a plurality of screen members and a support means for supporting the screen members. Each of the screen members is at least temporarily attached relative to the support means such that in use, the screen members define a screen. When the screen is struck by an object, at least one of the screen members is at least partially dislodged to allow passage of the object in a substantially uninhibited manner.
Patent NZ-572215-A (NZ)
Title: System and process for automatically controlling the flight of power wing airfoils
Inventor: MASSIMO IPPOLITO
IPC: F03D7/00
Filed: 2006-05-10
Abstract: A system (1) for automatically controlling the flight of at least one power wing airfoil (2) is disclosed. The power wing airfoil (2) is controlled by a driving unit (9) equipped with two winches to which the power wing airfoil is connected by two respective driving cables. The system includes: first detecting means (3) on board of the power wing airfoil (2) to detect first pieces of information (3a) dealing with at least one position and one orientation in space of the power wing airfoil and accelerations to which the power wing airfoil is subjected; second detecting means (5) on the ground to detect second pieces of information (5a) dealing with at least one amount of a tension on the driving cables of the power wing airfoil and a position of a counterweight of the driving unit; processing and controlling means (7) of the first and the second pieces of information (3a, 5a) to transform content of the pieces of information into a mechanical drive operating on the winches of the driving unit (9) to drive the power wing airfoil (2) along a flight trajectory maximising a "lift" effect generated on the power wing airfoil (2) by an Aeolian current in which the power wing foil is immersed and maximising an amount of kinetic energy subtracted from the Aeolian current; and a transmission system to transmit the first pieces of information to the processing and controlling means.
Patent NZ-572380-A (NZ)
Title: Stable aqueous suspension having palatable taste
Inventor: BLAKELY WILLY
IPC: A61K31/403
Filed: 2007-05-10
Abstract: Disclosed is an aqueous pharmaceutical suspension comprising: (i) at least one non-steroidal anti-inflammatory drug such as meloxicam (ii) an aqueous buffer system; (iii) xanthan gum; (iv) polyvinyl pyrrolidone; and (v) glycerol for treating arthritis.
Patent NZ-572463-A (NZ)
Title: Angioplasty medical devices made of elastomeric material
Inventor: BOTTICINI CESARE
IPC: A61L29/04
Filed: 2006-05-12
Abstract: Disclosed is a medical device or parts thereof for angioplasty, which is made of elastomeric material, characterized in that said elastomeric material comprises a polyamide-based polymer obtained from the polymerization of a compound forming polyamide blocks that is selected from the group consisting of an aminocarboxylic acid of Formula (1) and a lactam of Formula (2) with a polyether diamine triblock compound of Formula (3) and a dicarboxylic acid of Formula (4), wherein the groups R1, R2 and R3 are each binding groups comprising a hydrocarbon chain therein that may be interrupted by one or more amide groups; x is an integer from 1 to 20; y is an integer from 4 to 50, z is an integer from 1 to 20 and m is 0 or 1.
Patent NZ-572526-A (NZ)
Title: Structured glycerol esters useful as edible moisture barriers
Inventor: KLEMANN LAWRENCE PAUL
IPC: A21D2/16
Filed: 2008-11-04
Abstract: An edible moisture barrier composition comprising a mixture of structured glycerol ester compositions having the general formula (A) where each R group independently represents a short fatty acid residue "S" of 2 to 4 carbons, a medium fatty acid residue "M" having 6 to 12 carbons, or a saturated long fatty acid residue L having 14 to 22 carbons, the mixture comprising about 23 to about 70 percent SSL triacylglycerols and about 6 to about 30 percent SML triacylglycerols, and wherein the molar ratio of [M]j[S] residues in the mixture is about 0.1 to about 0.5 and the molar ratio of [S+M]j[L] residues is about 0.7 to about 2.0, and wherein the mixture of structured glycerol ester compositions contains a stable alpha crystal phase.
Patent NZ-574710-A (NZ)
Title: Combination treatment comprising the PDE4 inhibitor Compound A ((2R,4aR, 10bR)6-(2,6-Dimethoxy-pyridin-3-yl)-9-ethoxy-8-methoxy-1 ,2,3,4,4a,10b-hexahydrophenanthridin-2-ol) for diabetes mellitus
Inventor: KLEIN THOMAS
IPC: A61K31/473
Filed: 2007-09-04
Abstract: Disclosed are compositions that comprise (2R,4aR,10bR)-6-(2,6-Dimethoxy-pyridin-3-yl)-9-ethoxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol and a dipeptidyl-peptidase IV inhibitor. The dipeptidyl-peptidase IV inhibitor can be sitagliptin, saxagliptin, vildagliptin, denagliptin, alogliptin or P32/98. The compositions are used for the treatment diabetes mellitus type 2.
Patent NZ-577394-A (NZ)
Title: Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions
Inventor: PADIGARU MURALIDHARA
IPC: C12Q1/68
Filed: 2007-11-19
Abstract: Disclosed is a method for predicting the response of a patient to a drug employed in the treatment of an inflammatory condition in the patient, the method comprising: measuring the level of epiregulin gene expression in a blood sample from the patient to whom the drug has been administered; correlating the level of epiregulin gene expression in the patient's blood sample with the response to the treatment of the inflammatory condition, wherein elevated epiregulin level is indicative of positive response to the drug; and predicting the response of a patient to the drug employed in the treatment of the inflammatory condition. Further disclosed is a method of monitoring drug response in a patient receiving treatment for an inflammatory condition with an anti-inflammatory compound, the method comprising: measuring the level of epiregulin gene expression in a blood or serum sample from the patient to whom the anti-inflammatory compound has been administered; correlating the level of epiregulin gene expression in the patient's blood or serum sample with the patients response to the anti-inflammatory compound, wherein elevated epiregulin level is indicative of positive response to the anti-inflammatory compound; and monitoring drug response in the patient receiving treatment for inflammatory condition with the anti-inflammatory compound.
Patent NZ-579103-A (NZ)
Title: Switched arrangement
Inventor: SHEPPARD RODERICK JOHN
IPC: H01H1/38
Filed: 2008-01-17
Abstract: An electrical switching arrangement (30) includes a plug member which is adapted to be received into a general purpose electrical outlet; at least one outlet (12) to which at least one electrical appliance can be connected thereto; and, interposed switching means (21) which controls the electrical connection between the plug member and the at least one outlet. The switching means comprises a remote switch which is connected via a first flexible conductor (13) to a switching portion in which switching takes place, and the at least one outlet is connected via a second flexible conductor (32) to the switching portion.
Patent NZ-580681-A (NZ)
Title: Glycated milk and uses thereof
Inventor: ELLIOTT ROBERT BARTLETT
IPC: A61K38/08
Filed: 2008-04-24
Abstract: Provided is a method for manufacturing an edible beverage or food product characterised in that the method comprises (a) acquiring AI type bovine milk, (b) adding a glycation promoting carbohydrate material or ascorbic acid, (c) causing glycation of bovine milk proteins during or after a high-temperature sterilising treatment, and (d) packing the product. The product contains a glycated peptide which has a soporific effect.
Patent NZ-581321-A (NZ)
Title: Duck embryonic derived stem cell lines for the production of viral vaccines
Inventor: GUEHENNEUX FABIENNE
IPC: A61K39/145
Filed: 2008-04-23
Abstract: Disclsoed is a process for obtaining continuous genetically stable avian cell lines derived from avian embryonic stem cells (ES), wherein said avian cell lines are capable of proliferating in a basal medium in the absence of exogenous growth factors, serum and/or feeder layer and do not produce replication-competent endogenous retrovirus particles, said process comprising the steps of: a) isolating bird embryo(s) at a developmental stage around oviposition, wherein the genome of said bird does not contain endogenous proviral sequences susceptible to produce replication competent endogenous retroviral particles; b) suspending avian embryonic stem (ES) cells obtained by dissociating embryo(s) of step a) in a complete culture comprising: Insulin Growth factor 1 (IGF-1) and Ciliary Neurotrophic factor (CNTF) as only growth factors; and animal serum; c) seeding the suspension of ES cells obtained in step b) on a layer of feeder cells and further culturing the ES cells for at least one passage; d) withdrawing IGF-1 and CNTF from the culture medium, and further culturing the cells for at least one passage; e) progressively decreasing the concentration of feeder cells in the culture medium so as to obtain a total withdrawal of feeder layer after several passages, and further culturing the cells; and f) obtaining adherent avian cell lines derived from ES cells capable of proliferating in a basal medium in the absence of growth factors, feeder layer, and wherein said continuous genetically stable avian cell lines do not produce replication-competent endogenous retrovirus particles.
Patent NZ-581566-A (NZ)
Title: Flange for a pump with a keyed plastic liner having an internal thread
Inventor: HUANG SHOU-HSIUNG
IPC: F16L23/032
Filed: 2009-12-01
Abstract: A flange (1) with a composite assembly is disclosed. The flange (1) incorporates a plastic lining (20) to reduce cost, weight and corrosion. In detail the flange (1) comprises an outer base (10) having a mounting panel (11) with a through hole formed in it. Multiple fastening holes (112) are formed through the mounting panel and arranged around the through hole, adjacent to the edge. A recess (113) is formed in a lower surface of the mounting panel (11). An outer tube (12) formed on the upper surface of the mounting panel extends the through hole and an inner lining (20) is mounted inside with keys (114, 212, 121, 222) for proper alignment. A positioning panel attached to the inner lining is positioned in the recess (113). The lining has a threaded wall (221) formed on its inside wall.
Patent NZ-584579-A (NZ)
Title: Multi-component footbed with an insole base and a arch support insert
Inventor: LUTHI SIMON M
IPC: A43B7/22
Filed: 2008-09-15
Abstract: Disclosed is a footbed (200) for an individual's foot having forefoot, rear foot, lateral and medial column, and arch and metatarsal head areas. The footbed has an insole base (201) for underlying the forefoot and rear foot areas and portions of the lateral column area between the forefoot and rear foot areas. The footbed has an arch support insert (220) with a curved flexible upper portion (221) that forms an arch for accommodating the individual's medial arch, and a flat stiff lower portion (222) attached to the ends of the upper portion to stabilize the upper portion. The footbed further has means for attaching the metatarsal pad and arch support inserts to the insole base to provide support for the metatarsal head and arch areas of the foot, respectively.
Patent NZ-590699-A (NZ)
Title: Methods and devices for monitoring the integrity or a fluid connection
Inventor: HERTZ THOMAS
IPC: A61M1/36
Filed: 2009-06-26
Abstract: 590699 A method and a device for monitoring the integrity of a fluid connection (C) between first and second fluid containing systems (S1, S2) based on at least one time-dependent measurement signal from at least one pressure sensor (4a to 4c) in the first fluid containing system (S1) are disclosed. The first fluid containing system comprises a first pulse generator, and the second fluid containing system (S2) comprises a second pulse generator, and the at least one pressure sensor is arranged to detect first pulses originating from the first pulse generator and second pulses originating from the second pulse generator. The device comprises means (28) for receiving the at least one measurement signal; means (52) for obtaining timing information indicative of the timing of the second pulses in the at least one measurement signal; means (52) for processing the at least one measurement signal based on the timing information, to calculate a parameter value indicative of presence or absence of the second pulses; and means (52) for determining the integrity of the fluid connection based at least partly on the parameter value.
Patent NZ-595688-A (NZ)
Title: Convoluted chocolate product with regions of weakness and process for preparation thereof
Inventor: DOLAN VINCENT
IPC: A23G1/00
Filed: 2010-05-18
Abstract: 595688 A confectionery product (1) is disclosed comprising a convoluted chocolate sheet (14) having fold lines (16a, 16b) arranged generally along a first direction (10). The sheet (14) has at least one region of weakness (18) extending along the full width of the chocolate sheet (14) in a single plane transverse to the first direction (10). A method and apparatus for forming such a product by scraping the sheet of chocolate off a roller is also disclosed
Patent NZ-595916-A (NZ)
Title: Photosynthetic reactor for cultivating microorganisms, and method for cultivating microorganisms with reaction pipe and gas injection and exhaust
Inventor: MULLER-FEUGA ARNAUD
IPC: C12M1/00
Filed: 2010-03-09
Abstract: The apparatus relates to a photosynthetic reactor (1) for cultivating photosynthetic microorganisms, particularly algae, including at least one photosynthetic reaction pipe (2), at least one return pipe (3), at least one means (4) for circulating the liquid culture medium, at least one gas injection means (5), and at least one exhaust means (6) placed on the top portion of the reactor (1), wherein the placement of the gas injection means (5) and/or the formation of the reaction pipe (2) or return pipe (3) are designed such that the gas injected by the injection means (5) rises again to the exhaust means (6) while circulating in the reaction pipe (2) in a low-to-high flow direction so that the injected gas and the liquid culture medium set up a two-phase gas/liquid flow in a substantially horizontal reaction section (23) of the reaction channel (2). The apparatus can be used in the field of cultivating photosynthetic microorganisms and in particular algae.
Patent NZ-597019-A (NZ)
Title: Tiglien-3-one derivatives
Inventor: GORDON VICTORIA ANNE
IPC: A01N45/00
Filed: 2006-12-22
Abstract: 597019 Disclosed are bioactive natural products which may be obtainable from Fontainea australis, Fontainea borealis, Fontainea fugax, Fontainea oraria, Fontainea picrosperma, Fontainea rostrata, Fontainea subpapuana, Fontainea venosa or Hylandia dockrillii (Blushwood Tree). Isolated compounds from Fontainea picrosperma include: 12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one (EBI-46 / EBC-46), 12,13-di-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-tigliaen-3-one (EBI-47), 12-(dodeca-2,4,6-trienoyl)-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one (EBI-59), 12-(deca-2,4-dienoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one (EBI-61), 12,13-di-(2-methylbutanoyl)-1,2-2H-1,2,6,7-diepoxy-6-carboxy-4,5,9,12,13-pentahydroxy-tigliaen-3-one and 12,13-di-(2-methylbutanoyl)-5,20-di-acetoyl-4,5,9,12,13,20-hexahydroxy-tigliaen-3-one. Also disclosed is a composition which comprises a tiglien-3-one derivative such as those presented above, for the treatment of leukaemia, a solid tumour cancer, including melanoma, prostate cancer, breast cancer, ovarian cancer, basal cell carcinoma, squamous cell carcinoma, fibrosarcoma, colon cancer or lung cancer or other solid tumours.
Patent NZ-599534-A (NZ)
Title: Hose assembly including hose having inner and outer plies and filler layer of varying thickness, and end fitting having retention beads
Inventor: ZANDIYEH ALI REZA KAMBIEZ
IPC: F16L11/08
Filed: 2009-01-22
Abstract: A hose pump assembly including a hose having inner and outer plies (20, 22) with a filler layer (24) between the plies, and an end fitting (38). The end fitting includes a tubular portion (40) having a first end (42) over which an end of the hose extends, and a second end (44) with a fitting flange (46) located at the second end. The fitting has first and second retention bead s (48, 50) formed on the outer surface of the tubular portion for retention of the inner and outer plies respectively. The filler layer decreases in thickness towards the end of the hose.